Literature DB >> 536844

Accumulation of radioiodinated L-alpha-methyltyrosine in pancreas of mice: concise communication.

U Tisljar, G Kloster, F Ritzl, G Stöcklin.   

Abstract

L-3-iodo-alpha-methyltyrosine, labeled with either I-131 or I-123, has a high pancreatic specificity in mice. A pancreas-to-liver ratio of 8.6 +/- 2.7 is observed during the first hour after i.v. injection. Accumulation is also prominent in the kidneys, but excretion of the radioagent is rapid, 50% of the activity being eliminated during 90 min. Compared with L-[75Se]selenomethionine, the compound currently used for pancreatic imaging, L-3-[123I]or[131I]iodo-alpha-methyltyrosine has a higher pancreas-to-liver ratio, a shorter physical half-life and biological half-time, and better decay characteristics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 536844

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  The history of 123-iodo-methyl tyrosine.

Authors:  H J Biersack
Journal:  Eur J Nucl Med       Date:  2001-03

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

3.  Radiation doses to the eye lens from ocular tumour seeking radiopharmaceuticals.

Authors:  R Weinreich; H Bockslaff
Journal:  Eur J Nucl Med       Date:  1983

4.  An artificial amino acid radiopharmaceutical for single photon emission computed tomographic study of pancreatic amino acid transports 123I-3-iodo-alpha-methyl-L-tyrosine.

Authors:  K Kawai; Y Fujibayashi; Y Yonekura; J Konishi; H Saji; A Kubodera; A Yokoyama
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

5.  Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.

Authors:  H Bockslaff; M Spitznas; I Hahn; G Kloster
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

6.  Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.

Authors:  H Bockslaff; G Kloster; D Dausch; K Schad; H Hundeshagen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

7.  Uptake and distribution of L-3-[I-125] iodo-alpha-methyl tyrosine in experimental rat tumours: comparison with blood flow and growth rate.

Authors:  B Deehan; P Carnochan; M Trivedi; A Tombs
Journal:  Eur J Nucl Med       Date:  1993-02

8.  Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.

Authors:  B Bubeck; M Eisenhut; U Heimke; K zum Winkel
Journal:  Eur J Nucl Med       Date:  1981

9.  Canine SPECT studies for cerebral amino acid transport by means of 123I-3-iodo-alpha-methyl-L-tyrosine and preliminary kinetic analysis.

Authors:  K Kawai; Y Fujibayashi; Y Yonekura; K Tanaka; H Saji; J Konishi; A Kubodera; A Yokoyama
Journal:  Ann Nucl Med       Date:  1995-02       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.